| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 11, 2024 4:30 P.M. |
| Form: | S-1 | |||||
|
Attachments
Disclaimer
Enveric Biosciences Inc. published this content on 11 September 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on September 12, 2024 at 10:03:39 UTC.
